• Je něco špatně v tomto záznamu ?

Diaminocyclopentane - l-Lysine Adducts: Potent and selective inhibitors of human O-GlcNAcase

P. Weber, P. Bojarová, J. Brouzdová, V. Křen, N. Kulik, AE. Stütz, M. Thonhofer, TM. Wrodnigg

. 2024 ; 148 (-) : 107452. [pub] 20240518

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013361

A new class of compounds, namely highly substituted diaminocyclopentane-l-lysine adducts, have been discovered as potent inhibitors of O-GlcNAcase, an enzyme crucial for protein de-O-glycosylation. These inhibitors exhibit exceptional selectivity and reversibility and are the first example of human O-GlcNAcase inhibitors that are structurally related to the transition state of the rate-limiting step with the "aglycon" still in bond-length proximity. The ease of their preparation, remarkable biological activities, stability, and non-toxicity make them promising candidates for the development of anti-tau-phosphorylation agents holding significant potential for the treatment of Alzheimer's disease.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013361
003      
CZ-PrNML
005      
20240905133320.0
007      
ta
008      
240725e20240518xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bioorg.2024.107452 $2 doi
035    __
$a (PubMed)38763001
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Weber, Patrick $u Glycogroup, Institute of Chemistry and Technology of Biobased Systems, Graz University of Technology, Stremayrgasse 9, A-8010 Graz, Austria. Electronic address: patrick.weber@tugraz.at
245    10
$a Diaminocyclopentane - l-Lysine Adducts: Potent and selective inhibitors of human O-GlcNAcase / $c P. Weber, P. Bojarová, J. Brouzdová, V. Křen, N. Kulik, AE. Stütz, M. Thonhofer, TM. Wrodnigg
520    9_
$a A new class of compounds, namely highly substituted diaminocyclopentane-l-lysine adducts, have been discovered as potent inhibitors of O-GlcNAcase, an enzyme crucial for protein de-O-glycosylation. These inhibitors exhibit exceptional selectivity and reversibility and are the first example of human O-GlcNAcase inhibitors that are structurally related to the transition state of the rate-limiting step with the "aglycon" still in bond-length proximity. The ease of their preparation, remarkable biological activities, stability, and non-toxicity make them promising candidates for the development of anti-tau-phosphorylation agents holding significant potential for the treatment of Alzheimer's disease.
650    _2
$a lidé $7 D006801
650    12
$a inhibitory enzymů $x chemie $x farmakologie $x chemická syntéza $7 D004791
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    12
$a lysin $x chemie $x farmakologie $7 D008239
650    _2
$a beta-N-acetylhexosaminidasy $x antagonisté a inhibitory $x metabolismus $7 D001619
650    _2
$a cyklopentany $x chemie $x farmakologie $x chemická syntéza $7 D003517
650    _2
$a molekulární struktura $7 D015394
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bojarová, Pavla $u Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, CZ 14220 Prague 4, Czech Republic
700    1_
$a Brouzdová, Jitka $u Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, CZ 14220 Prague 4, Czech Republic
700    1_
$a Křen, Vladimír $u Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, CZ 14220 Prague 4, Czech Republic
700    1_
$a Kulik, Natalia $u Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, CZ 14220 Prague 4, Czech Republic
700    1_
$a Stütz, Arnold E $u Glycogroup, Institute of Chemistry and Technology of Biobased Systems, Graz University of Technology, Stremayrgasse 9, A-8010 Graz, Austria. Electronic address: stuetz@tugraz.at
700    1_
$a Thonhofer, Martin $u Glycogroup, Institute of Chemistry and Technology of Biobased Systems, Graz University of Technology, Stremayrgasse 9, A-8010 Graz, Austria
700    1_
$a Wrodnigg, Tanja M $u Glycogroup, Institute of Chemistry and Technology of Biobased Systems, Graz University of Technology, Stremayrgasse 9, A-8010 Graz, Austria
773    0_
$w MED00000771 $t Bioorganic chemistry $x 1090-2120 $g Roč. 148 (20240518), s. 107452
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38763001 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133314 $b ABA008
999    __
$a ok $b bmc $g 2143275 $s 1225227
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 148 $c - $d 107452 $e 20240518 $i 1090-2120 $m Bioorganic chemistry $n Bioorg Chem $x MED00000771
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...